Philip Morris is a leading dividend business with strong smoke-free product growth, including IQOS and ZYN. Read why PM stock ...
Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with ...
(Reuters) -Cigarette giant Philip Morris International on Thursday ... PMI's flagship heated tobacco device IQOS, and its traditional cigarette business would deliver again in 2025.
Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.
Together with IQOS, shipments of oral smoke-free products exceeded 40 billion units for the first time increasing revenue by 14% and boosting gross profits by nearly 19%. The third reason Philip ...
Jacek Olczak; Chief Executive Officer, Director; Philip Morris International Inc ... Importantly, the growth of IQOS is increasingly profitable as the benefits of scale and pricing more than ...
Philip Morris ended a strong 2024 with another solid quarter, including organic net revenue growth of 7.3% and organic operating income growth of 11.8%. Management expects more of the same for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results